Smilax Laboratories Limited

U24230TG2004PLC044461ActivePublic · Non-govt companyRoC-HyderabadUnlisted
Last updated: 2026-06-08
100
Compliance Health · A · provisional
4 / 4 signals passed

Smilax Laboratories Limited is a Public Non-govt company company incorporated in 2004 and based in Telangana, India. Smilax Laboratories Limited operates in Manufacture of pharmaceuticals, medicinal chemicals and botanical products (NIC 24230) with authorized capital of ₹97.00 Cr and paid-up capital of ₹96.04 Cr. For 2022-23, the company reported revenue of ₹267.39 Cr and profit after tax of ₹3.77 Cr. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.

Risk FlagsAGM 1776d ago · may be overdue
Revenue (latest FY)
₹267.39 Cr
2022-23
PAT (latest FY)
₹3.77 Cr
Margin 1.4%
Open Charges
0
No encumbrances
Active Directors
3
No resignations
Paid-up Capital
₹96.04 Cr
99% of authorized
Filings on Record
0
All current
Incorporated
2004
22 years old
State
Telangana
Sector
Manufacture of pharmaceuticals, medicinal chemicals and botanical products
NIC 24230
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹97.00 Cr
Paid-up Capital
₹96.04 Cr
99% utilized
Members
Last AGM
20 Oct 2021
1776d ago
Last Balance Sheet
31 Mar 2021
1979d ago
Latest Filing
Registered Email
g*****(at)ramky.com
Registered Office
PLOT NO 12/A PHASE III IDA JEEDIMETLA Hyderabad TG 500055 IN

Quick facts

Identity · Activity · Auditor · Contact
Registered office
PLOT NO 12/A PHASE III IDA JEEDIMETLA Hyderabad TG 500055 IN
NIC code
24230
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
g*****(at)ramky.com
Section
Manufacture of pharmaceuticals, medicinal chemicals and botanical products
ROC
RoC-Hyderabad
Website
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
20 Oct 2004 · 20 Oct 2021

Directors

3 activeNo resignations on record

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2521 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+8dfiled
MGT-7FY2023-2422 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2324 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Smilax Laboratories Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
681602298Kotak Mahindra Bank Ltd(Bank)₹2.09 Cr19 Sep 2021Satisfied
962838270HDFC Bank Ltd(Bank)₹2.15 Cr12 Mar 2020Satisfied
744110455Kotak Mahindra Bank Ltd(Bank)₹11.17 Cr19 Sep 2022Open
614104799HDFC Bank Ltd(Bank)₹15.53 Cr12 Mar 2019Satisfied
361221493Kotak Mahindra Bank Ltd(Bank)₹22.55 Cr12 Mar 2019Open
See registered charges & lenders

Charge IDs, lenders & amounts for Smilax Laboratories Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

MCA6 reporting years
Revenue (bars) vs PAT (line) by FY
Revenue PAT
₹0₹275.88 Cr₹551.75 Cr₹827.63 Cr₹675.14 Cr₹788.21 Cr₹533.43 Cr₹252.64 Cr₹312.00 Cr₹687.19 Cr2016-172017-182019-202020-212021-222022-23
FYRevenuePATNet WorthTotal AssetsEmployees
2022-23
2021-22
2020-21
2019-20
2017-18
2016-17

Detailed Financials

4 FYsIncome statement + balance sheet
Line item2022-232021-222020-212019-20
Income statement
Revenue from operations
Other income
Total income
Total expenses
Profit before tax
Profit / (Loss) after tax
Balance sheet
Equity / Net worth
Borrowings
Current liabilities
Total liabilities
Current assets
Cash & equivalents
Total assets
Employees

Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.

Compounded Annual Growth Rate

Derived from multi-FY filings
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue2022-23+56.0%+45.0%+91.0%
Profit after Tax2022-23
Net Worth2022-23+2.0%-7.0%+7.0%

Financial Ratios

Profitability · leverage · efficiency
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
2016-17-9.22%-14.31%-4.10%
2017-18-12.29%+8.30%-15.69%-6.15%
2019-20-0.51%+24.18%-0.82%-0.35%
2020-21+0.99%+18.36%+1.86%+0.84%
2021-22-6.42%-14.72%-11.41%-4.93%
2022-23+1.41%+33.66%+3.24%+1.50%

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters32,35,37,89576.99%
Institutional Investors235,11,89611.49%
Public & Others5935,22,67011.52%
See the full shareholding pattern

Promoter, institutional & public holding for Smilax Laboratories Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

9 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Top quartile · P100
PAT (latest FY)
Top quartile · P100
Employees
Paid-up capital
Top quartile · P100
Compliance Health
96
96
96
Bottom quartile · P0

Top 10 in Manufacture of pharmaceuticals, medicinal chemicals and botanical products

by healthView all ›
01
Watson Pharma Private Limited
Maharashtra · Inc 2005
Paid-up
Revenue
A · 96
02
Wockhardt Limited
Maharashtra · Inc 1999
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Natco Pharma Limited
Telangana · Inc 1981
Paid-up
Revenue
A · 96
06
Paid-up
Revenue
A · 96
07
Lyka Labs Limited
Gujarat · Inc 1976
Paid-up
Revenue
A · 96
08
Genworks Health Private Limited
Karnataka · Inc 2015
Paid-up
Revenue
A · 96
09
Ajanta Pharma Limited
Maharashtra · Inc 1979
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

Events & timeline

4Filings, charges, board changes
20 Oct 2021
Surender appointed as Director
20 Oct 2021
Saibaba Reddy appointed as Director
20 Sept 2019
Ramakrishna Reddy appointed as Director
20 Oct 2004
Company incorporated
Smilax Laboratories Limited registered with RoC-Hyderabad; year 2004

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Smilax Laboratories Limited

When was Smilax Laboratories Limited incorporated?
Smilax Laboratories Limited was incorporated in 2004 (around 20 Oct 2004). Its CIN is U24230TG2004PLC044461 and it is registered with RoC-Hyderabad.
Where is Smilax Laboratories Limited located?
Smilax Laboratories Limited is headquartered in Telangana, at: PLOT NO 12/A PHASE III IDA JEEDIMETLA Hyderabad TG 500055 IN .
What sector does Smilax Laboratories Limited operate in?
Smilax Laboratories Limited operates in the Manufacture of pharmaceuticals, medicinal chemicals and botanical products sector (NIC code 24230), classified as Non-govt company.
Who are the directors of Smilax Laboratories Limited?
Smilax Laboratories Limited has 3 active directors: Surender (Director), Saibaba Reddy (Director), Ramakrishna Reddy (Director).
What is the paid-up capital of Smilax Laboratories Limited?
Smilax Laboratories Limited has authorized capital of ₹97.00 Cr and paid-up capital of ₹96.04 Cr.
Does Smilax Laboratories Limited have any open charges?
Smilax Laboratories Limited has no open MCA-registered charges on record.
What is Smilax Laboratories Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Smilax Laboratories Limited is 100/100 (grade A), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 4 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.